Provided by Tiger Trade Technology Pte. Ltd.

ESSA Pharma

0.2012
0.0000
Volume:- -
Turnover:1.16M
Market Cap:9.52M
PE:-0.35
High:0.2012
Open:0.2012
Low:0.2012
Close:0.2012
52wk High:6.45
52wk Low:0.1800
Shares:47.31M
Float Shares:26.07M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5692
EPS(LYR):-0.6446
ROE:-21.25%
ROA:-15.25%
PB:0.09
PE(LYR):-0.31

Loading ...

Company Profile

Company Name:
ESSA Pharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. The company develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. It has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.